华兰生物 (002007)

Hualan Biological Engineering Inc.

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 182745.67
  • Circulating A-Shares(W): 157370.29
  • Earnings Per Share(RMB): 0.4291
  • Net Assets Per Share(RMB): 6.2228
  • Operating Revenue(W RMB): 337888.64
  • Total Profit(W RMB): 97241.42
  • Net Profit Attributable to Parent(W RMB): 78442.30
  • Net Profit Growth Rate(%): -15.07
  • Weighted Return on Equity(%): 6.5500
  • Operating Cash Flow Per Share(RMB): 0.2470
  • Undistributed Profit Per Share(RMB): 3.9619
  • Capital Reserve Per Share(RMB): 0.7795

2. Main Business

The main business covers:

  • Blood products
  • Vaccines
  • R&D, production and sales of genetic engineering products

3. Company Basic Information

  • Company Name: Hualan Biological Engineering, Inc.
  • Listing Date: 2004-06-25
  • Industry: Pharmaceutical Manufacturing
  • Address: No.1 A Hualan Avenue, Xinxiang City, Henan Province
  • Website: www.hualanbio.com
  • Company Profile: The company is a foreign-invested joint-stock company established through the overall transformation of Hualan Biological Engineering Co., Ltd., approved by the Ministry of Foreign Trade and Economic Cooperation [2000] WJMZ No. 658 and the People's Government of Henan Province YGPZ [2000] No. 40.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Chongqing Shengkang Biotechnology Development Co., Ltd. General Legal Person 27443.87 17.44
2 Hong Kong Kekang Co., Ltd. General Legal Person 23989.40 15.24
3 Hong Kong Securities Clearing Company Ltd. Northbound Funds 2997.75 1.90
4 Shouchuang Securities Co., Ltd. Broker 1988.02 1.26
5 CSI 500 ETF Fund 1593.78 1.01
6 China Merchants Guozheng Biopharmaceutical Index Securities Investment Fund (LOF) Class A Fund 1445.91 0.92
7 Yongxin County Shengkang Xinkai Enterprise Management Consulting Center (Limited Partnership) General Legal Person 1350.20 0.86
8 ChinaAMC Guozheng Vaccine and Biotechnology Index Initiation Securities Investment Fund Class A Fund 46.33 0.03
9 Harvest CSI Vaccine and Biotechnology ETF Fund 45.18 0.03
10 Penghua Guozheng Vaccine and Biotechnology ETF Fund 36.44 0.02

5. Concept Sectors

  • Biological Vaccine
  • Gene Concept
  • Hepatitis Concept
  • Innovative Drug
  • Margin Trading & Securities Lending
  • Heavily Held by Brokers
  • High Dividend Stocks
  • Spin-off Listing
  • SME 100
  • SZSE 300
  • Technology 100
  • SME 300

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information